A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

BACKGROUND: The outbreak of a new coronavirus (SARS-CoV-2) poses a great challenge to global public health. New and effective intervention strategies are urgently needed to combat the disease. METHODS: We conducted an open-label, non-randomized, clinical trial involving moderate COVID-19 patients ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Weihui, Liu, Yan, Xia, Lu, Li, Min, Song, Zhigang, Hu, Huiliang, Yang, Zongguo, Wang, Lin, Cheng, Xiaobo, Wang, Mei, Jiang, Rongrong, Liu, Li, Mao, Xiaoting, Chen, Jun, Ling, Yun, Zhang, Lin, Yan, Jin, Shan, Fei, Steinhart, Corklin, Zhang, Xiaoyan, Zhu, Tongyu, Xu, Jianqing, Lu, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388798/
https://www.ncbi.nlm.nih.gov/pubmed/32838238
http://dx.doi.org/10.1016/j.eclinm.2020.100478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388798/
https://www.ncbi.nlm.nih.gov/pubmed/32838238
http://dx.doi.org/10.1016/j.eclinm.2020.100478

Ejemplares similares